David Kirn, Chief Executive Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 172,254 shares at $23.56 ($4.0M) on 2022-12-15, disclosed to the SEC on 2022-12-19.
Open-market sale of $4.0M FDMT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.56 | 31,433 | $741K | 18.5% |
| 2 | $23.56 | 31,433 | $741K | 18.5% |
| 3 | $24.13 | 1,500 | $36K | 0.9% |
| 4 | $22.66 | 27,595 | $625K | 15.6% |
| 5 | $22.66 | 27,595 | $625K | 15.6% |
| 6 | $23.39 | 26,349 |
| $616K |
| 15.4% |
| 7 | $23.39 | 26,349 | $616K | 15.4% |
| Total | $23.22 avg | 172,254 | $4.0M | 100% |
| Filing → |
| FDMT | SELL | 2026-08-21 | $1.1M | — | Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |